跳至主要内容
临床试验/CTRI/2024/04/066492
CTRI/2024/04/066492尚未招募2 期

A pilot study of metabolic syndrome metasynthesis of holistic medicine(homoeopathy) and integrative medicine. - nil

Metropolitan Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • We will be considering patients who can satisfy any 3 out of these 5 criteria as per The National Cholesterol Education Program: Adult Treatment Panel III(NCEP: ATP III) later modified by American Heart Association(AHA) & National Heart, Lung and Blood Institute(NHLBI- 1)Abdominal obesity- = 102 cm (40 inches) in males and = 88 cm (35 inches) in females. 2)Hypertension- =130 mm Hg systolic blood pressure ; =85 mm Hg diastolic blood pressure or under antihypertensive drug treatment in a patient with a history of hypertension. 3)Hyperglycemia- =100 mg/dL or under drug treatment for elevated glucose. 4)Hypertriglyceridemia- =150 mg/dL (1.7mmol/ L) or under drug treatment for elevated triglycerides. 5)Low high density lipoprotien cholesterol levels- less than 40 mg/dL in males and less then 50 mg/dL in females or under drug treatment for reduced HDL-C levels

排除标准

  • 1) Patients suffering from AIDS, cancer along with metabolic syndrome are excluded.
  • 2)Pregnant & lactating women are excluded.
  • 3)Patients with life threatening diagnosed heart and neurological disorders.

研究者

发起方
Metropolitan Homoeopathic Medical College and Hospital

相似试验